JP2017502946A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502946A5
JP2017502946A5 JP2016539089A JP2016539089A JP2017502946A5 JP 2017502946 A5 JP2017502946 A5 JP 2017502946A5 JP 2016539089 A JP2016539089 A JP 2016539089A JP 2016539089 A JP2016539089 A JP 2016539089A JP 2017502946 A5 JP2017502946 A5 JP 2017502946A5
Authority
JP
Japan
Prior art keywords
radioactive
formula
radiotracer
radiopharmaceutical composition
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539089A
Other languages
English (en)
Japanese (ja)
Other versions
JP6824738B2 (ja
JP2017502946A (ja
Filing date
Publication date
Priority claimed from GBGB1322456.3A external-priority patent/GB201322456D0/en
Application filed filed Critical
Publication of JP2017502946A publication Critical patent/JP2017502946A/ja
Publication of JP2017502946A5 publication Critical patent/JP2017502946A5/ja
Application granted granted Critical
Publication of JP6824738B2 publication Critical patent/JP6824738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539089A 2013-12-18 2014-12-18 放射性トレーサー組成物及び方法 Active JP6824738B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1322456.3 2013-12-18
GBGB1322456.3A GB201322456D0 (en) 2013-12-18 2013-12-18 Radiotracer compositions and methods
PCT/EP2014/078609 WO2015091882A1 (en) 2013-12-18 2014-12-18 Radiotracer compositions and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019124883A Division JP2019206533A (ja) 2013-12-18 2019-07-04 放射性トレーサー組成物及び方法

Publications (3)

Publication Number Publication Date
JP2017502946A JP2017502946A (ja) 2017-01-26
JP2017502946A5 true JP2017502946A5 (enExample) 2017-12-28
JP6824738B2 JP6824738B2 (ja) 2021-02-03

Family

ID=50071052

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016539089A Active JP6824738B2 (ja) 2013-12-18 2014-12-18 放射性トレーサー組成物及び方法
JP2019124883A Withdrawn JP2019206533A (ja) 2013-12-18 2019-07-04 放射性トレーサー組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019124883A Withdrawn JP2019206533A (ja) 2013-12-18 2019-07-04 放射性トレーサー組成物及び方法

Country Status (6)

Country Link
US (3) US10300156B2 (enExample)
EP (1) EP3082879A1 (enExample)
JP (2) JP6824738B2 (enExample)
CN (1) CN105848687B (enExample)
GB (1) GB201322456D0 (enExample)
WO (1) WO2015091882A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
CN108218651B (zh) * 2018-02-27 2023-11-03 首都医科大学宣武医院 用于制备放射性药物的一次性辅助装置及方法
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
GB201919016D0 (en) * 2019-12-20 2020-02-05 Ge Healthcare Ltd Apparatus and method for solid phase extraction
MX2022008571A (es) * 2020-01-10 2022-11-30 Real Isolates Llc Metodos para la obtencion de compuestos a partir de un material vegetal o de hongos, composiciones respectivas y usos de los mismos.

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
GB0105224D0 (en) 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
TWI284539B (en) 2001-07-30 2007-08-01 Epix Pharm Inc A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide
AU2002357388A1 (en) 2001-12-27 2003-07-24 The United States Of America, As Represented By The Department Of Veterans Affairs Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
US7018614B2 (en) 2002-11-05 2006-03-28 Eastern Isotopes, Inc. Stabilization of radiopharmaceuticals labeled with 18-F
ES2347535T3 (es) * 2002-11-05 2010-11-02 Ion Beam Applications S.A. Estabilizacion de composiciones acuosas de 2-fluoro-2-desoxi-d-glucosa marcada con el isotopo 18f con etanol.
NO20030115D0 (no) 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
US20050214859A1 (en) 2003-03-03 2005-09-29 Dyax Corp. Peptides that specifically bind HGF receptor (cMet) and uses thereof
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0420344D0 (en) 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
JP5317475B2 (ja) 2005-10-24 2013-10-16 富士フイルムRiファーマ株式会社 肝細胞増殖因子受容体が関与する疾患の診断薬及び治療薬
CA2656487A1 (en) 2006-07-07 2008-01-17 The Board Of Trustees Of The Leland Stanford Junior University Selective caspase inhibitors
GB0615211D0 (en) 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
MX2009002492A (es) 2006-09-08 2009-08-28 Bayer Schering Pharma Ag Agentes que comprenden compuestos marcados con 18f y metodos relacionados.
WO2011008990A1 (en) 2009-07-15 2011-01-20 Prometheus Laboratories Inc. Drug selection for gastric cancer therapy using antibody-based arrays
US7902332B2 (en) 2006-11-30 2011-03-08 General Electric Company Fluorine-labeled compounds
US8247534B2 (en) 2006-12-13 2012-08-21 Ge Healthcare As Synthesis of radiofluorinated peptide using microwave activation technology
BRPI0721424A2 (pt) 2007-03-01 2014-03-25 Bayer Schering Pharma Ag Métodos de radiofluoração
RU2475266C2 (ru) 2007-05-16 2013-02-20 ДжиИ Хелткер АС Оптические агенты визуализации
GB0718967D0 (en) 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0718957D0 (en) 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
GB0716897D0 (en) 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment
US20090274623A1 (en) * 2008-01-30 2009-11-05 General Electric Company In vivo imaging agents for met receptor tyrosine kinase
GB0803477D0 (en) 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method
EP2268609B1 (en) * 2008-02-28 2013-01-30 GE Healthcare Limited Synthesis of a PEG-6 moiety from commercial low-cost chemicals
US8435454B2 (en) * 2009-07-09 2013-05-07 Siemens Medical Solutions Usa, Inc. Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure
EP2287197A1 (en) 2009-08-21 2011-02-23 Pierre Fabre Medicament Anti-cMET antibody and its use for the detection and the diagnosis of cancer
GB0918321D0 (en) 2009-10-20 2009-12-02 Ge Healthcare As Cyclic peptide synthesis
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
CA2819347A1 (en) 2010-12-01 2012-06-07 Ge Healthcare Limited Radioconjugation method
GB201020314D0 (en) 2010-12-01 2011-01-12 Ge Healthcare Ltd Apoptosis pet imaging agents
KR20130124522A (ko) * 2010-12-09 2013-11-14 지이 헬쓰케어 리미티드 방사성 추적자 조성물
MX2013007364A (es) * 2010-12-21 2014-03-21 Ge Healthcare Ltd Uso de anilina en la radioestabilizacion de ligadura de oxima.
SG191338A1 (en) 2010-12-22 2013-07-31 Ge Healthcare Ltd Her2 binding peptides labelled with a 18f - containing organosilicon compound
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201121914D0 (en) 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322451D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Purification method and compositions
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods

Similar Documents

Publication Publication Date Title
JP2017502946A5 (enExample)
CN102712603B (zh) 放射性碘标记方法
JP2022136074A (ja) 新規製剤及び合成方法
CA2807491A1 (en) F18 c-met binding cyclic peptide radiotracers and compositions thereof
KR20110006658A (ko) 직접적인 친핵성 절차를 위한 정제 전략
CN103889930B (zh) 用于制备68Ga络合物的工艺
Haveman et al. State of the art procedures towards reactive [18F] fluoride in PET tracer synthesis
Craig et al. Preparation of labeled aromatic amino acids via late-stage 18 F-fluorination of chiral nickel and copper complexes
KR102109225B1 (ko) 18f-플루시클로빈의 제조
EP4305009A2 (en) Aliphatic 18f-radiolabeling of a tetrazine precursor
ES2892034T3 (es) Proceso para la purificación de Ga-68 a partir del eluato derivado de generadores de 68Ge/ 68Ga
US20100228060A1 (en) Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination
US20140127130A1 (en) Radiofluorinated compounds and their preparation
Wang et al. Synthesis and biological evaluation of 18F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging
FR2949113A1 (fr) Composes a base de sultones, leurs derives substitues par des nucleophiles, notamment des radionucleides, procedes et applications
JP2017501152A5 (enExample)
JP2015516457A (ja) 放射性医薬品の製造用キット及び製造方法
Wadsak et al. 18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers
WO2018233798A1 (en) Novel psma-binding agents and uses thereof
KR102084472B1 (ko) 다양한 압타머에 적용 가능한 방사성동위원소 표지된 핵산 구조체 개발 및 표지방법
WO2013113801A2 (en) Chelating agents
Chiotellis et al. Synthesis, characterization and biological evaluation of novel neutral fac-M (CO) 3 (SNO) complexes (M= Re, 99mTc) bearing the o-methoxyphenylpiperazine moiety
JP2016515564A (ja) 放射標識法
Meltzer et al. A second-generation 99mTechnetium single photon emission computed tomography agent that provides in vivo images of the dopamine transporter in primate brain
US20160022845A1 (en) Synthon composition